Marker Predicts Good Results With Stem CellsMedPage TodaySurvival improved by 60% and disease progression decreased by 62% in 313 patients who received allogeneic hematopoietic stem cells containing killer-cell immunoglobulin-like receptor 2DL1 (KIR2DL1). Patients benefited regardless of the indication for read more
http://blog.zandcell.com/marker-predicts-good-results-with-stem-cells-medpage-today/?utm_source=rss&utm_medium=rss&utm_campaign=marker-predicts-good-results-with-stem-cells-medpage-today
Inga kommentarer:
Skicka en kommentar